Inovio Pharmaceuticals (INO) Receivables (2010 - 2026)
Inovio Pharmaceuticals (INO) reported Receivables of $41,000 for Q2 2026, down 95.1% from $840,312 a year earlier but up 20.6% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Receivables (2010 - 2026) Analysis & Trends
At the end of FY2025, Inovio Pharmaceuticals posted Receivables of $450.00, down 100.0% from FY2024.
- Receivables has declined for three consecutive years, with a five-year compound annual growth rate of -88.1% (FY2020 to FY2025).
- By year, Receivables came in at $1.2 million in FY2024 (-50.1%), $2.41 million in FY2023 (-89.0%), $21.77 million in FY2022 (+140.2%) and $9.07 million in FY2021 (-52.4%).
- Five-year quarterly Receivables spans a low of $450.00 in Q4 2025 and a high of $21.64 million in Q4 2022.
- Year over year, Receivables has now declined in each of the last 14 quarters, with an average decline of 63.1% over the last eight quarters.
- The high point for year-over-year Receivables in five years was Q4 2022 (growth of 247.6%); the low point was Q4 2025 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $34,000 (Q1 2026), $450.00 (Q4 2025) and $978,590 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Inovio Pharmaceuticals | 99.58 Mn | 99.58 Mn | - | 41,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 450.00 |
| Sep 30, 2025 | 978,590.00 |
| Jun 30, 2025 | 840,312.00 |
| Mar 31, 2025 | 1.31 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 2.55 Mn |
| Dec 31, 2023 | 2.41 Mn |
| Sep 30, 2023 | 2.14 Mn |
| Jun 30, 2023 | 5.11 Mn |
| Mar 31, 2023 | 5.04 Mn |
| Dec 31, 2022 | 21.64 Mn |
| Sep 30, 2022 | 10.08 Mn |
| Jun 30, 2022 | 11.37 Mn |
| Mar 31, 2022 | 7.50 Mn |
| Dec 31, 2021 | 6.23 Mn |
| Sep 30, 2021 | 7.13 Mn |
API Access
Inovio Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();